Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

OraSure Technologies Teams With The Reed For Hope Foundation, Singer/Songwriter/Actress Keri Hilson and Dr. Rachael Ross to



OraSure Technologies Teams With The Reed For Hope Foundation,
Singer/Songwriter/Actress Keri Hilson and Dr. Rachael Ross to Encourage
America to Get Tested for HIV

BETHLEHEM, Pa., June 26, 2013 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc.
(Nasdaq:OSUR) today announced that it has teamed up with The Reed For Hope
Foundation and their new ambassador, award-winning singer/songwriter/actress
Keri Hilson, and medical doctor and sexologist Dr. Rachael Ross, to encourage
individuals to get tested for HIV on National HIV Testing Day on June 27^th
using the new OraQuick^® In-Home HIV Test.

National HIV Testing Day is an annual observance created to encourage
Americans to get tested for the HIV virus. This year marks the first
observance of National HIV Testing Day when consumers have the option of
purchasing the OraQuick^® In-Home HIV Test – the only FDA-approved
over-the-counter rapid HIV test, which now empowers consumers to get tested
with the same test used by healthcare professionals.

OraQuick^® In-Home HIV Test Educational Campaign Media Tour

As part of its ongoing educational and awareness efforts, OraSure has teamed
up with The Reed For Hope Foundation and its "Love Healthy" campaign which
encourages loved ones to be healthy and test for HIV.

The Reed For Hope Foundation (RFHF), which was founded by Emmy Award Winning
Casting Director Robi Reed, aims to raise awareness, gather resources, and
build alliances with other charities and organizations in the fight to stop
preventable diseases like HIV, eliminate health disparities and inspire
general wellness.

RFHF's Love Healthy Ambassador Keri Hilson and Dr. Rachael Ross will be making
media appearances in New York City on June 26^th and 27^th in support of the
campaign. The tour is part of an integrated marketing program that includes
events, as well as national and local radio, outdoor, television, print and
digital advertising.

"We are honored to be working with Ms. Hilton and Dr. Ross, The Reed For Hope
Foundation, and so many dedicated state and local organizations to raise
awareness of the importance of HIV testing, and help reduce the fear and
stigma often associated with testing," said Douglas A. Michels, President and
Chief Executive Officer of OraSure Technologies. "Now consumers have direct
access to the OraQuick In-Home HIV Test – the same test healthcare
professionals have used for years. They can now learn their HIV status in the
privacy of their own homes."

2013 National HIV Testing Day Consumer Perception/Attitude Survey

OraSure also released the results from its "2013 National HIV Testing Day
Consumer Perception/Attitude Survey," which surveyed 1,000 sexually active
adults on perception of risk for HIV and common barriers to getting tested for
HIV.

The survey found wide disparities between HIV risk perception and behavior
among the consumers surveyed, and underscored the need for more education and
awareness around HIV testing. More information and key findings of the
OraQuick National HIV Testing Day Survey can be found at
http://www.oraquick.com/media.

According to the Centers for Disease Control and Prevention (CDC), there are
approximately 1.2 million people in the U.S. that have HIV and approximately
240,000 of them are unaware of their status. Those who do not know they are
HIV positive are disproportionately responsible for the 50,000 new HIV
infections that occur each year.

Approved by the U.S. Food and Drug Administration (FDA) in July 2012, the
OraQuick® In-Home HIV Test is the first rapid infectious disease test ever to
be made available directly to consumers for in-home use. The OraQuick® In-Home
Test was named one of the "Best Inventions of 2012" by TIME and was also named
a "Top Health Breakthrough of 2012" by Men's Health magazine. The product is
an over-the-counter version of the OraQuick ADVANCE® Rapid HIV-1/2 Antibody
Test, an oral swab rapid HIV test with more than 25 million units sold in the
professional market, including doctors, hospitals, clinics and other trained
professionals.

To ensure optimal support for individuals using the OraQuick® In-Home HIV
Test, OraSure offers live support and comprehensive referral services 24 hours
a day, seven days a week, every day of the year, through a toll-free support
center and comprehensive consumer website at www.oraquick.com. The OraQuick®
Support Center is staffed with highly trained, bi-lingual (English/Spanish)
representatives who are available by telephone at 866-436-6527 to answer
questions about HIV/AIDS and using and interpreting the test. They also
provide referrals to follow-up and care, and can take orders for the OraQuick
In-Home HIV Test. Additionally, the product website provides access to
resources and referral to follow-up counseling, confirmatory testing and
medical care.

For more information on the OraQuick® In-Home HIV Test, visit
www.OraQuick.com.

About OraSure Technologies

OraSure Technologies is a leader in the development, manufacture and
distribution of oral fluid diagnostic and collection devices and other
technologies designed to detect or diagnose critical medical conditions. Its
innovative products include rapid tests for the detection of antibodies to HIV
and HCV at the point of care and testing solutions for detecting various drugs
of abuse. In July 2012, the Company received approval from the U.S. Food and
Drug Administration for the Company's OraQuick® In-Home HIV Test for sale
directly to consumers in the over-the-counter (OTC) market - making it the
first and only rapid OTC HIV test approved in the U.S. In addition, the
Company is a leading provider of oral fluid sample collection, stabilization
and preparation products for molecular diagnostic applications. OraSure's
portfolio of products is sold globally to various clinical laboratories,
hospitals, clinics, community-based organizations and other public health
organizations, research and academic institutions, distributors, government
agencies, physicians' offices, and commercial and industrial entities. The
Company's products enable healthcare providers to deliver critical information
to patients, empowering them to make decisions to improve and protect their
health.

For more information on OraSure Technologies, please visit www.orasure.com.

CONTACT: Media Contact:
         Jennifer Moritz
         Zer0 to 5ive for OraSure Technologies
         917-748-4006
         jmoritz@0to5.com

company logo
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement